CLARIFICATION

CLARIFICATION Date: May 27, 1996 An item in the Notebook section of the April 29, 1996, issue of The Scientist (page 30) reported on a recent presentation by Godfrey Oakley, director of the division of birth defects and developmental disabilities at the Centers for Disease Control and Prevention in Atlanta, discussing folic acid taken by women of reproductive age. Oakley says the currently recommended 400 µg dose of folic acid per day is sufficient to prevent births of babie

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

An item in the Notebook section of the April 29, 1996, issue of The Scientist (page 30) reported on a recent presentation by Godfrey Oakley, director of the division of birth defects and developmental disabilities at the Centers for Disease Control and Prevention in Atlanta, discussing folic acid taken by women of reproductive age. Oakley says the currently recommended 400 µg dose of folic acid per day is sufficient to prevent births of babies with spina bifida and neural tube defects. However, he adds, the Food and Drug Administration recently required that as of Jan. 1, 1998, grain products be fortified with 140 µg folic acid per 100 g grain. This requirement is insufficient, according to Oakley, who recommends that grain products be fortified at about 700 µg per 100 g of grain.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA